The Omnicell Blog
The pharmacy world is changing fast. The emergence of pharmacy intelligence, predictive analytics, and increasing demand for a complete end-to-end solution means healthcare leaders must innovate to meet both new medication management challenges (COVID-19) and old (diversion, patient safety, and rising costs).
The Omnicell Blog is the leading source for pharmacy information on emerging trends, successful best practices, and ideas and insights to help pharmacies digitally transform to lower cost and improve patient safety.
Why Implementing a Robust IV Workflow System Is Key to Patient Safety
Despite the reality that intravenous (IV) compounding is among the highest risk areas in the continuum of acute care when it comes to the potential for possible patient harm, IV systems are often the last to be impacted by advances in pharmacy automation.
How a Democrat-Controlled Senate Could Impact the Biden Administration’s COVID-19 Vaccine Rollout
The Democrats’ recent sweep of the United States Senate Georgia runoff elections means the Democrats will control both chambers of Congress as well as the White House for the first time since 2010. A number of Democratic leaders in Congress consider this as a clear mandate to aggressively pursue their agenda and enact “bold change.”
An Inside Look at the Latest Governmental and Industry Developments Shaping the 340B Program
As the economic slowdown and rising unemployment levels have disproportionately impacted the underprivileged and uninsured—many that are served by 340B covered entities—the financial pressures are mounting for providers.
How Advances in Cloud Computing Can Impact Big Data for Pharmacy
Advances in cloud computing and its adoption make it possible and powerful for the pharmacy data to be integrated into the overall health system, care continuum, and patient journey. Cloud is also empowering pharmacists to leverage predictive analytics and benchmarking to accurately optimize medication inventory management through quality, trusted data.
Turnkey Services Are Advancing Adoption of Central Pharmacy Automation
The benefits of a fully autonomous pharmacy are widely recognized – reduced medication errors, less waste, improved efficiencies, more opportunity to focus on higher-value patient care. Yet many pharmacies are still putting off the adoption of autonomous solutions.
Latest Innovation in Winter 2020 Release Advances Journey to the Autonomous Pharmacy
The need for solutions designed to help customers achieve greater visibility, control costs, and better manage an increasingly complex pharmacy supply chain is more important than ever. Omnicell’s Winter 2020 release features new capabilities that advance the journey to the fully Autonomous Pharmacy.
Robust Communication and Program Management Expertise are Musts for a Successful Technology Implementation
The key to successful implementation and adoption of new technology starts with strong program management that can help to build consensus, clearly communicate goals, and leverage KPIs to monitor and measure milestones before, during, and post-implementation.
Implications of Recent Federal Actions to Address High Prescription Drug Costs
An estimated 140 bills on drug prices have been introduced in Congress since January 2019; however, partisan differences have precluded passage of any substantive legislation in this area. The inaction by the legislative branch led President Donald Trump to sign on July 24 four executive orders aimed at reducing drug prices and ensuring access to medications.
Advocates for Safe IV Preparation Practices Share Their Inspiration Podcast
Seminal research from 1997 on IV compounding discovered that 9 percent of manually compounded sterile preparations had incorrect ingredients and/or volumes. While a study from two decades ago may no longer seem relevant, the fact is, the vast majority of today’s IVs are still being prepared through error-prone manual processes.
340B Advocates Face an Important Decision at a Critical Juncture
Since the Affordable Care Act (ACA) was enacted a decade ago, most 340B provider advocates have preached caution, as 340B providers scored significant victories in the ACA. These wins included expanding the 340B program to include rural hospitals, increasing pricing transparency and providing additional oversight over drug manufacturers. Ever since, 340B advocates have been largely playing defense – reacting, rather than setting the agenda.
People Fear Change – But Being Prepared Can Facilitate Adoption
As health systems continue to adopt new technologies and digital transformations, it often causes a dramatic shift that can be jolting and confusing for staff. Successful adoption of these newer, more sophisticated solutions doesn’t need to be scary or complicated.
ASHP Midyear 2020: The Journey to Zero-Error Medication Management
I invite you to join us during ASHP Midyear 2020 to learn how the Autonomous Pharmacy is transforming inefficient, error-prone, manual processes to help pharmacies enhance safety, improve efficiency, and drive business outcomes.
The views and opinions expressed in this blog are those of the authors and do not necessarily reflect the official policy or position of any other agency, organization, employer or company. Assumptions made in the analysis are not reflective of the position of any entity other than the author(s). These views are always subject to change, revision, and rethinking at any time and may not be held in perpetuity.